Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Azam, Ghafoor"'
Autor:
Massimo Fantini, Kwong Y Tsang, Christina Annunziata, Philip Arlen, Anjum Zaki, Sharon Mavroukakis, Charalampos S Floudas, Jamie Hur, Azam Ghafoor, Ann McCoy, Erica Redmond, Christine Feierabend
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/db95603f19224ab78a0c8f0e533912fb
Autor:
Azam Ghafoor, MD, Idrees Mian, MD, Cathy Wagner, BSN, Yvonne Mallory, BSN, Maria Garcia Agra, BSN, Betsy Morrow, BS, Jun S. Wei, PhD, Javed Khan, MD, Anish Thomas, M.B.B.S., MD, Manjistha Sengupta, PhD, Seth M. Steinberg, PhD, Raffit Hassan, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 10, Pp 100231- (2021)
Introduction: PARP inhibition may enhance antitumor responses in BAP1-associated mesothelioma by inducing synthetic lethality. Methods: A single-center, nonrandomized, phase 2 trial was conducted, in which patients with refractory mesothelioma were g
Externí odkaz:
https://doaj.org/article/d58aa11f4d9f4b56b290574901b887da
Autor:
Azam Ghafoor, Zishuo I. Hu, Markku Miettinen, Martha Quezado, Cathy Wagner, Kenneth Aldape, Raffit Hassan, Alexandra P. Lebensohn, Maria Agra, Yvonne Mallory
Publikováno v:
Journal of Thoracic Oncology. 17:461-466
BAP1 is a tumor suppressor gene implicated in DNA repair and cell growth. Individuals with germline BAP1 mutations are at a significantly increased risk for developing many different cancers including malignant mesothelioma, uveal melanomas, cutaneou
Autor:
Omotola O, Olasupo, Craig, Haddix, Charles, Nakar, Jennifer, Maahs, Anne, Greist, Azam, Ghafoor, Sharyne M, Donfield, Alfonso, Iorio, Amy D, Shapiro
Publikováno v:
European Journal of Haematology. 108:232-243
To describe the Indiana Hemophilia and Thrombosis Center (IHTC) surgical database, its key components, and exploratory analyses of surgeries conducted between 1998 and 2019.Surgical data across bleeding disorders collected retrospectively (1998-2006)
Autor:
Azam Ghafoor, Raffit Hassan
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 17(7)
Autor:
Azam Ghafoor, Akram Almakki
Publikováno v:
Avicenna Journal of Medicine, Vol 04, Iss 02, Pp 44-47 (2014)
A 69 year old male referred to nephrology clinic for uncontrolled hypertension. During his follow up over two years, he developed renal disease and hypercalcemia. He was found to have monoclonal gammopathy (MGUS). Urinalysis was negative except for M
Externí odkaz:
https://doaj.org/article/18e4ae8f797c4629a1676b259878199a
Publikováno v:
Cancer
Malignant mesothelioma is an aggressive cancer with a poor prognosis and limited treatment options. For many years, the only US Food and Drug Administration-approved first-line treatment for unresectable mesothelioma was pemetrexed plus cisplatin. Ho
Autor:
Jun S. Wei, Maria Agra, Cathy Wagner, Seth M. Steinberg, Anish Thomas, Javed Khan, Azam Ghafoor, Betsy Morrow, Raffit Hassan, Manjistha Sengupta, Idrees Mian, Yvonne Mallory
Publikováno v:
JTO Clinical and Research Reports
JTO Clinical and Research Reports, Vol 2, Iss 10, Pp 100231-(2021)
JTO Clinical and Research Reports, Vol 2, Iss 10, Pp 100231-(2021)
Introduction PARP inhibition may enhance antitumor responses in BAP1-associated mesothelioma by inducing synthetic lethality. Methods A single-center, nonrandomized, phase 2 trial was conducted, in which patients with refractory mesothelioma were giv
Autor:
Azam Ghafoor, Fang Wei, Udayan Guha, Wei Liao, Trinh Hoc Tran Pham, Mark Raffeld, Liqiang Xi, Seth M. Steinberg, Hadi Bagheri, Clive Morris, Nina Monkash, Gregory D. Jones, Jordan Cheng, Michael Tu, David Chia, Ahmad Shafiei, Constance M. Cultraro, Charles M. Strom, Vikram Misra, Elizabeth Akoth, Chul Kim, Nitin Roper, David T.W. Wong
Publikováno v:
Cancers
Cancers, vol 13, iss 13
Volume 13
Issue 13
Cancers, Vol 13, Iss 3342, p 3342 (2021)
Cancers, vol 13, iss 13
Volume 13
Issue 13
Cancers, Vol 13, Iss 3342, p 3342 (2021)
Simple Summary ctDNA assay is a promising non-invasive method to detect genomic alterations associated with lung cancer. In this prospective study of 25 patients with EGFR-mutant lung adenocarcinoma receiving osimertinib, ctDNA progression predated r
Publikováno v:
Journal of Thoracic Oncology. 15:e25-e27